Updated: Eli Lilly’s tirzepatide breaks into obesity market with FDA approval
Eli Lilly’s tirzepatide is officially entering the market for chronic weight management. The drugmaker said Wednesday that the GIP/GLP-1 receptor […]
Eli Lilly’s tirzepatide is officially entering the market for chronic weight management. The drugmaker said Wednesday that the GIP/GLP-1 receptor […]
The FDA approved tirzepatide (Zepbound), the latest injectable for chronic weight management in adults, the agency announced on Wednesday. The
Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to
The US Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults with obesity or overweight.
Tirzepatide is already approved for diabetes under the brand name Mounjaro where it competes with Novo Nordisk’s diabetes drug semaglutide,
ST. GEORGE — For Mitsy Olsen, losing weight was not only a physical transformation but also a journey of discovering
What You Should Know: Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities
Creatine 101: Exactly What Need To Know About This Trending Peptide Supplement If you’re an athlete, you’ve probably wondered if
Mechano growth factor (MGF) is a compound that occurs naturally in skeletal muscle, cardiac muscle, nervous tissue, and muscle. Pegylated
An investigational brain-penetrant, pegylated analogue of the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide (Byetta, Bydureon) known as NLY01 did not